These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33146565)

  • 1. Microvesicles in bronchoalveolar lavage as a potential biomarker of COPD.
    Bazzan E; Radu CM; Tinè M; Neri T; Biondini D; Semenzato U; Casara A; Balestro E; Simioni P; Celi A; Cosio MG; Saetta M
    Am J Physiol Lung Cell Mol Physiol; 2021 Feb; 320(2):L241-L245. PubMed ID: 33146565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-alveolar neutrophil-derived microvesicles are associated with disease severity in COPD.
    Soni S; Garner JL; O'Dea KP; Koh M; Finney L; Tirlapur N; Srikanthan K; Tenda ED; Aboelhassan AM; Singh S; Wilson MR; Wedzicha JA; Kemp SV; Usmani OS; Shah PL; Takata M
    Am J Physiol Lung Cell Mol Physiol; 2021 Jan; 320(1):L73-L83. PubMed ID: 33146567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different inflammatory cell pattern and macrophage phenotype in chronic obstructive pulmonary disease patients, smokers and non-smokers.
    Löfdahl JM; Wahlström J; Sköld CM
    Clin Exp Immunol; 2006 Sep; 145(3):428-37. PubMed ID: 16907910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic obstructive pulmonary disease.
    Hodge S; Hodge G; Ahern J; Jersmann H; Holmes M; Reynolds PN
    Am J Respir Cell Mol Biol; 2007 Dec; 37(6):748-55. PubMed ID: 17630319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smoking status and anti-inflammatory macrophages in bronchoalveolar lavage and induced sputum in COPD.
    Kunz LI; Lapperre TS; Snoeck-Stroband JB; Budulac SE; Timens W; van Wijngaarden S; Schrumpf JA; Rabe KF; Postma DS; Sterk PJ; Hiemstra PS;
    Respir Res; 2011 Mar; 12(1):34. PubMed ID: 21426578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADAM15 expression is increased in lung CD8
    Wang X; Zhang D; Higham A; Wolosianka S; Gai X; Zhou L; Petersen H; Pinto-Plata V; Divo M; Silverman EK; Celli B; Singh D; Sun Y; Owen CA
    Respir Res; 2020 Jul; 21(1):188. PubMed ID: 32677970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of oxidised self-lipids and alveolar macrophage CD1b expression in COPD.
    Ween MP; White JB; Tran HB; Mukaro V; Jones C; Macowan M; Hodge G; Trim PJ; Snel MF; Hodge SJ
    Sci Rep; 2021 Feb; 11(1):4106. PubMed ID: 33602992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease.
    Ferhani N; Letuve S; Kozhich A; Thibaudeau O; Grandsaigne M; Maret M; Dombret MC; Sims GP; Kolbeck R; Coyle AJ; Aubier M; Pretolani M
    Am J Respir Crit Care Med; 2010 May; 181(9):917-27. PubMed ID: 20133931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bronchoalveolar lavage in COPD: fluid recovery correlates with the degree of emphysema.
    Löfdahl JM; Cederlund K; Nathell L; Eklund A; Sköld CM
    Eur Respir J; 2005 Feb; 25(2):275-81. PubMed ID: 15684291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages.
    Létuvé S; Kozhich A; Arouche N; Grandsaigne M; Reed J; Dombret MC; Kiener PA; Aubier M; Coyle AJ; Pretolani M
    J Immunol; 2008 Oct; 181(7):5167-73. PubMed ID: 18802121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of T-cell subsets in BAL fluid of patients with mild to moderate COPD depends on current smoking status and not airway obstruction.
    Forsslund H; Mikko M; Karimi R; Grunewald J; Wheelock ÅM; Wahlström J; Sköld CM
    Chest; 2014 Apr; 145(4):711-722. PubMed ID: 24264182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular cadmium in the bronchoalveolar space of long-term tobacco smokers with and without COPD and its association with inflammation.
    Sundblad BM; Ji J; Levänen B; Midander K; Julander A; Larsson K; Palmberg L; Lindén A
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1005-13. PubMed ID: 27274222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of chronic obstructive pulmonary disease.
    Shaykhiev R; Krause A; Salit J; Strulovici-Barel Y; Harvey BG; O'Connor TP; Crystal RG
    J Immunol; 2009 Aug; 183(4):2867-83. PubMed ID: 19635926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of γδ and other T-lymphocyte subsets in patients with chronic obstructive pulmonary disease and asthma.
    Urboniene D; Babusyte A; Lötvall J; Sakalauskas R; Sitkauskiene B
    Respir Med; 2013 Mar; 107(3):413-23. PubMed ID: 23273406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of induced sputum and bronchoalveolar lavage fluid from patients with chronic obstructive pulmonary disease on neutrophil migration in vitro.
    Babusyte A; Jeroch J; Stakauskas R; Stravinskaite K; Malakauskas K; Sakalauskas R
    Medicina (Kaunas); 2010; 46(5):315-22. PubMed ID: 20679746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smoking reduces surfactant protein D and phospholipids in patients with and without chronic obstructive pulmonary disease.
    Moré JM; Voelker DR; Silveira LJ; Edwards MG; Chan ED; Bowler RP
    BMC Pulm Med; 2010 Oct; 10():53. PubMed ID: 20973980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease.
    Soler N; Ewig S; Torres A; Filella X; Gonzalez J; Zaubet A
    Eur Respir J; 1999 Nov; 14(5):1015-22. PubMed ID: 10596683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of IL-32 in Serum, Induced Sputum Supernatant, and Bronchial Lavage Fluid of Patients with Chronic Obstructive Pulmonary Disease.
    Gasiuniene E; Lavinskiene S; Sakalauskas R; Sitkauskiene B
    COPD; 2016 Oct; 13(5):569-75. PubMed ID: 27018873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased macrophage release of TGF-beta and TIMP-1 in chronic obstructive pulmonary disease.
    Pons AR; Sauleda J; Noguera A; Pons J; Barceló B; Fuster A; Agustí AG
    Eur Respir J; 2005 Jul; 26(1):60-6. PubMed ID: 15994390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microparticles in sputum of COPD patients: a potential biomarker of the disease?
    Lacedonia D; Carpagnano GE; Trotta T; Palladino GP; Panaro MA; Zoppo LD; Foschino Barbaro MP; Porro C
    Int J Chron Obstruct Pulmon Dis; 2016; 11():527-33. PubMed ID: 27042041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.